Synthetic DNA enables life sciences research that can be applied to pressing societal challenges across many sectors, but could also be used in the development of biological parts, systems, or organisms that cause great harm to human, public, or environmental health. Many companies that produce and sell synthetic DNA screen ordered sequences to prevent customers from inappropriately accessing Sequences of Concern (SOCs). This project aims to improve DNA synthesis screening by enabling the development of better tools and mechanisms for screening performance evaluation.
Workshop 6 will focus on Implementation of the 2024 OSTP Framework for Nucleic Acid Synthesis Screening. On a practical level, what resources and implementation support are needed? What will be the biggest implementation challenges? Who still needs information/education and how can "we" get it to them?
Discussion will include most or all of the six actions Providers and Manufacturers should take to adhere to the OSTP Framework. An agenda will be shared with registrants in advance of the workshop.